What is OKYO Pharma Limited (EMMLF)?

OKYO Pharma Limited (EMMLF) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of EMMLF?

The current price of EMMLF is $0.01. Prices are updated in real time on Stocks360.

What is EMMLF's market capitalization?

EMMLF's market capitalization is $22,725,423.00, placing it in the small-cap tier.

OKYO Pharma Limited (EMMLF)

Stock analysis · OTC · Healthcare · Biotechnology

$0.01

Market Cap

$22.73M

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-0.06

Day Range

$0.01 – $0.01

52-wk Range

$0.01 – $0.89

Avg Volume

N/A

Volume

10.10K

OKYO Pharma Limited (EMMLF) is a publicly traded company in the Healthcare sector. Latest price: $0.01. Market cap $22.73M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About OKYO Pharma Limited

OKYO Pharma Limited is an early-stage biopharmaceutical company focused on developing therapies for individuals experiencing inflammatory eye conditions and ocular pain. A key asset in their pipeline is OK-101, specifically aimed at treating dry eye disease. Additionally, the company is advancing OK-201, which is a preclinical lipidated-peptide analogue sourced from bovine adrenal medulla, intended for the management of neuropathic ocular pain. Founded in 2007, OKYO Pharma Limited is headquartered in London, United Kingdom.